Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rangnekar

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
Cancer Research|December 4, 2012
Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4Ravshan Burikhanov, Tripti Shrestha-Bhattarai, Shirley Qiu, et al.
Cancer Research|October 3, 2007
Cancer resistance in transgenic mice expressing the SAC module of Par-4Yanming Zhao, Ravshan Burikhanov, Shirley Qiu, et al.
Tetrahedron Letters|August 4, 2015
Development of <i>6H</i>-Chromeno[3,4-<i>c</i>]pyrido[3',2':4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 SecretagoguesMykhaylo S Frasinyuk, Svitlana P Bondarenko, Vitaliy M Sviripa, et al.
Surgical Endoscopy|March 26, 2005
Role of pancreatic duct stenting in the treatment of chronic pancreatitisG C Vitale, K Cothron, E A Vitale, et al.
The Journal of Biological Chemistry|January 31, 1998
Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1M M Ahmed, S F Sells, K Venkatasubbarao, et al.
ACS Applied Materials & Interfaces|August 27, 2021
Thermoreflectance Imaging of (Ultra)wide Band-Gap Devices with MoS<sub>2</sub> Enhancement CoatingsRiley Hanus, Sonal V Rangnekar, Shahab Mollah, et al.
Cancer Biology & Therapy|May 27, 2011
Systemic Par-4 inhibits non-autochthonous tumor growthYanming Zhao, Ravshan Burikhanov, Jason Brandon, et al.
Journal of the American Chemical Society|September 25, 2010
Weave tile architecture construction strategy for DNA nanotechnologyMajken N Hansen, Alex M Zhang, Abhijit Rangnekar, et al.
Cancer Causes & Control : CCC|November 30, 2018
Potential protein markers for breast cancer recurrence: a retrospective cohort studyChunyan He, Rina Plattner, Vivek Rangnekar, et al.
Cancer Biology & Therapy|May 29, 2015
Anti-cancer activity of withaferin A in B-cell lymphomaM K McKenna, B W Gachuki, S S Alhakeem, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Cancer Research|December 4, 2012
Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4Ravshan Burikhanov, Tripti Shrestha-Bhattarai, Shirley Qiu, et al.
Cancer Research|October 3, 2007
Cancer resistance in transgenic mice expressing the SAC module of Par-4Yanming Zhao, Ravshan Burikhanov, Shirley Qiu, et al.
Tetrahedron Letters|August 4, 2015
Development of <i>6H</i>-Chromeno[3,4-<i>c</i>]pyrido[3',2':4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 SecretagoguesMykhaylo S Frasinyuk, Svitlana P Bondarenko, Vitaliy M Sviripa, et al.
Surgical Endoscopy|March 26, 2005
Role of pancreatic duct stenting in the treatment of chronic pancreatitisG C Vitale, K Cothron, E A Vitale, et al.
The Journal of Biological Chemistry|January 31, 1998
Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1M M Ahmed, S F Sells, K Venkatasubbarao, et al.
ACS Applied Materials & Interfaces|August 27, 2021
Thermoreflectance Imaging of (Ultra)wide Band-Gap Devices with MoS<sub>2</sub> Enhancement CoatingsRiley Hanus, Sonal V Rangnekar, Shahab Mollah, et al.
Cancer Biology & Therapy|May 27, 2011
Systemic Par-4 inhibits non-autochthonous tumor growthYanming Zhao, Ravshan Burikhanov, Jason Brandon, et al.
Journal of the American Chemical Society|September 25, 2010
Weave tile architecture construction strategy for DNA nanotechnologyMajken N Hansen, Alex M Zhang, Abhijit Rangnekar, et al.
Cancer Causes & Control : CCC|November 30, 2018
Potential protein markers for breast cancer recurrence: a retrospective cohort studyChunyan He, Rina Plattner, Vivek Rangnekar, et al.
Cancer Biology & Therapy|May 29, 2015
Anti-cancer activity of withaferin A in B-cell lymphomaM K McKenna, B W Gachuki, S S Alhakeem, et al.
Pageof 27